ENvue Medical, Inc.

FEED

ENvue Medical, Inc.

FEED

Insider Sentiment (TTM):

Last Purchase:2026-01-14Last Sale:2026-06-22Shares Purchased (TTM):240,000Shares Sold (TTM):212,918

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:79,463Shares Outstanding:3,289,049Institutional Ownership Pct.:2.42%

Earnings Market Reaction:

Filing Date:2026-08-17Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	1	2	4	7	4	1	1	1	-	-	-	-
Cash	-	-	4	-	-	1	1	1	2	3	3	4
Restricted Cash Current	0	0	-	-	-	-	-	-	-	-	-	-
Assets Current
Assets Current	5	6	7	10	7	4	3	4	5	6	6	7
Restricted Cash	-	0	0	0	0	0	-	-	-	-	-	-
Accounts Receivable Net Current	0	0	0	0	0	0	0	1	0	0	0	0
Prepaid Expense And Other Assets Current	-	-	-	1	1	1	0	0	0	0	0	0
Inventory Net	3	2	2	2	2	2	2	2	2	3	3	3
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	-	-	-	-	-	-	-	-	0	0	0	0
Assets Noncurrent
Assets Noncurrent	34	34	34	44	45	40	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable Net Noncurrent	0	0	0	0	-	-	-	-	-	-	-	-
Intangible Assets Net Excluding Goodwill	4	4	4	5	6	6	-	-	-	-	-	-
Goodwill	29	29	29	39	39	34	-	-	-	-	-	-
Assets	38	40	41	54	51	44	4	5	6	6	7	7
Liabilities And Stockhold…
Deferred Revenue	-	-	-	-	-	-	-	-	-	0	0	-
Accounts Payable Current	1	1	1	0	0	0	0	0	0	0	0	0
Other Accounts Payable And Accrued Liabilities	3	3	2	4	4	4	0	2	2	2	2	2
Liabilities Current
Liabilities Current	7	7	7	12	7	8	3	3	3	2	2	2
Unsecured Debt Current	-	-	-	-	-	1	-	-	-	-	-	-
Loans Payable	-	-	-	-	2	2	-	-	-	-	-	-
Deferred Income Current	-	-	-	-	-	0	0	0	0	-	0	-
Loans Payable Current	1	1	1	1	-	-	-	-	-	-	-	-
Contract With Customer Liability Current	-	-	0	-	-	-	0	-	-	-	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Noncurrent
Other Accrued Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Income Noncurrent	-	-	-	-	-	-	-	-	0	0	0	0
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	-	-
Liabilities	8	8	8	12	11	8	3	3	3	3	3	3
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	155	144	124	119	117	108	71	70	70	70	70	70
Stockholders Equity	31	32	33	42	40	36	1	2	3	4	4	5
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-124	-112	-90	-77	-76	-72	-70	-68	-67	-67	-66	-65
Liabilities And Stockholders Equity	38	40	41	54	51	44	4	5	6	6	7	7
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	40	40	40	40	40	40	40	40	40	40	40	40
Common Stock Shares Issued	8	4	1	1	1	0	0	0	0	0	0	0
Shares Outstanding	8	4	1	1	1	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-17.92%	-47.72%	-60.40%	-	-	-	-	-	-	-	-	-
2025	-20.93%	-25.66%	-37.98%	17.15%	14.08%	-16.06%	-6.11%	-44.57%	-26.92%	-31.21%	-49.77%	-69.94%
2024	12.23%	1.12%	5.20%	1.70%	-14.07%	-11.49%	17.37%	-5.95%	-14.24%	51.03%	-67.16%	-73.02%
2023	-	-	-	-	-	-	4.90%	1.47%	-6.86%	-13.67%	-5.09%	-17.89%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.66	0.90	1.09	0.86	1.05	0.47	1.22	1.74	2.11	2.45	2.64	3.00
Quick Ratio	0.31	0.57	0.74	0.62	0.64	0.12	0.31	0.75	1.04	1.26	1.47	1.60
Working Capital	-2.49M	-668.00K	611.00K	-1.63M	349.00K	-4.34M	609.00K	1.86M	2.83M	3.52M	4.03M	4.78M
Leverage & Debt
Debt to Equity	0.25	0.25	0.23	0.28	0.27	0.24	4.79	1.50	1.00	0.78	0.67	0.57
Interest Coverage TTM	-220.55	-106.21	-91.56	-33.26	-30.94	-31.60	-26.53	-21.75	-19.22	-21.84	-25.45	-43.55
Debt Ratio	0.20	0.20	0.19	0.22	0.21	0.19	0.83	0.60	0.50	0.44	0.40	0.36
Efficiency & Turnover
Asset Turnover TTM	0.04	0.05	0.11	0.09	0.08	0.11	0.50	0.55	0.71	0.52	0.36	0.16
Days Sales Outstanding TTM	30.32	57.74	27.66	56.55	47.13	49.22	29.68	33.94	30.30	26.77	26.14	46.90
Receivables Turnover TTM	12.04	6.32	13.19	6.45	7.75	7.42	12.30	10.75	12.05	13.64	13.96	7.78
Per Share Metrics
Diluted EPS TTM	-7.99	-11.41	-26.69	-5.34	-9.91	-79.68	-137.30	-11.01	-111.25	-129.65	-233.24	-28.80
Free Cash Flow Per Share TTM	-1.91	-3.77	-15.01	-8.48	-12.63	-52.50	-93.35	-8.78	-91.18	-120.74	-226.45	-25.82
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-26.06%	-12.43%	5.99%	30.02%	32.06%	45.57%	58.95%	59.62%	64.57%	68.98%	67.32%	49.80%
Operating Profit Margin TTM	-1,362.72%	-1,134.71%	-896.55%	-351.77%	-349.21%	-182.79%	-140.03%	-88.54%	-77.50%	-103.47%	-150.50%	-442.43%
Net Profit Margin TTM	-2,553.89%	-1,720.50%	-657.07%	-170.69%	-205.26%	-187.42%	-144.84%	-93.80%	-83.49%	-112.35%	-162.55%	-493.73%
Growth Metrics
Net Revenue Growth (1Y)	-17.66%	-18.07%	-0.20%	-18.41%	-30.66%	-6.60%	12.05%	227.79%	424.57%	241.73%	203.59%	-38.37%
Net Income Growth (1Y)	924.54%	652.13%	352.77%	48.46%	70.49%	55.81%	-0.16%	-37.72%	-45.69%	-40.85%	-31.88%	-15.25%
EPS Growth (1Y)	-19.37%	-85.68%	-80.56%	-51.52%	-91.09%	-38.54%	-41.13%	-61.77%	256.68%	295.65%	507.80%	-31.06%
Calculated Values
Free Cash Flow TTM	-11.74M	-12.41M	-9.43M	-7.28M	-6.12M	-3.29M	-2.52M	-2.46M	-2.31M	-2.98M	-3.60M	-4.44M
Net Debt	-4.00K	-1.19M	-3.17M	-5.91M	-4.03M	654.00K	-752.00K	-1.31M	-2.17M	-2.70M	-3.28M	-3.79M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Sale

Owner: Glibert, Christian Michae…

Title: -

Shares: 210,000

Price/Share: $0.69

Value: $144,900.00

Shares Owned: -

Relationship: Other

Ownership: Direct

2026-02-02Sale

Owner: Bank, Of America Corp /De…

Title: -

Shares: 2,918

Price/Share: $3.05

Value: $8,899.90

Shares Owned: 231,138

Relationship: TenPercentOwner

Ownership: Indirect

2026-01-14Purchase

Owner: Glibert, Christian Michae…

Title: -

Shares: 240,000

Price/Share: $2.67

Value: $640,800.00

Shares Owned: 240,000

Relationship: TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Glibert, Christian Michae…	Other	-	Direct	Sale	210,000	0.69	$144,900.00	0	4
2026-02-02	Bank, Of America Corp /De…	TenPercentOwner	-	Indirect	Sale	2,918	3.05	$8,899.90	231,138	4
2026-01-14	Glibert, Christian Michae…	TenPercentOwner	-	Direct	Purchase	240,000	2.67	$640,800.00	240,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

2.42%

Inst. Shares: 79,463

Shares Outstanding: 3,289,049

2025-12-31

2.93%

Inst. Shares: 18,405

Shares Outstanding: 628,534

2025-09-30

0.20%

Inst. Shares: 1,684

Shares Outstanding: 858,434

2025-06-30

4.02%

Inst. Shares: 19,503

Shares Outstanding: 484,566

2025-03-31

31.62%

Inst. Shares: 19,797

Shares Outstanding: 62,615

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	79,463	3,289,049	2.42%
2025-12-31	18,405	628,534	2.93%
2025-09-30	1,684	858,434	0.20%
2025-06-30	19,503	484,566	4.02%
2025-03-31	19,797	62,615	31.62%
2024-12-31	343,984	26,985	-
2024-09-30	410,908	280,318	146.59%
2024-06-30	233,248	25,312	-
2024-03-31	324,735	246,980	131.48%
2023-12-31	66,111	15,911	-
2023-09-30	96,535	172,103	56.09%
2023-06-30	41,378	166,233	24.89%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ENvue Medical, Inc. (FEED) — SEC Financial Statements & Analysis

ENvue Medical, Inc. (FEED) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. ENvue Medical, Inc. trades on Nasdaq as: FEED. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ENvue Medical, Inc. reported a -17.66% year-over-year revenue growth, a Gross Profit Margin of -26.06% (TTM), a Debt-to-Equity ratio of 0.25x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -17.66%
Gross Profit Margin TTM: -26.06%
Debt To Equity: 0.25x

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ENvue Medical, Inc. in?

ENvue Medical, Inc. (FEED) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What exchange does FEED trade on?

ENvue Medical, Inc. (FEED) trades on the Nasdaq.

Where is ENvue Medical, Inc. incorporated?

ENvue Medical, Inc. is incorporated in DE.